Business
Ocumetics Technology Corp. Provides Update on Preclinical Studies
(TheNewswire) Calgary, Alberta – TheNewswire - May 18, 202...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Technology Corp. Provides Update on Preclinical Studies \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Calgary, Alberta\n \n \n –\n \n \n TheNewswire -\n \n \n May 18, 2022 - Ocumetics Technology Corp. (“\n \n \n Ocumetics\n \n \n ”)\n(\n \n \n TSXV:OTC) is pleased to provide an update on\nthe status of preclinical studies for its first product, the Bionic\nLens.\n \n \n \n \n Since January 2022, Ocumetics has been busy undertaking\na series of studies using cadaver donor eyes to determine how\nOcumetics’ optical technologies would fit in the human eye. These\nstudies have led to design enhancements to perfect how the Bionic Lens\nconforms to the lens capsular bag of the human eye.\n \n \n \n \n The studies, and resulting design enhancements, were\nsupervised by Ocumetics’ regulatory approval expert, Dr. Barbara\nFant, Ocumetics’ founder and Chief Scientific Officer, Dr. Garth\nWebb, and Chief Medical Officer, Dr. Doyle Stulting.\n \n \n \n \n “We are focused on perfecting the design of the lens\ntechnology before we begin the regulatory approval process, which we\nexpect will begin shortly,” said Dr. Barbara Fant.\n \n \n \n \n Dr. Garth Webb added, “We have been experimenting\nwith different lens materials, and combinations thereof, to ensure we\nhave optimized the quality of the optics and the accommodation levels\nwe are seeking in the lens technology. We have also been experimenting\nwith different types of lens injectors to ensure the ophthalmologist\ncan maintain control of the injection process during surgery.”\n \n \n \n \n The ergonomics of installing the optical technologies\nhas also been an emphasis over the past 4-6 weeks.\n \n \n \n \n “We have received excellent feedback from the\nophthalmologists performing the cadaver surgeries,” says Dr. Doyle\nStulting. “We have used this feedback to ensure the process of\ninserting the Bionic Lens into the eye is as easy and intuitive as\npossible. If ophthalmologists enjoy the surgical process of installing\nthe Bionic Lens into the patient’s eye, they are much more likely to\nrecommend Ocumetics products to their patients.”\n \n \n \n \n “It has been a busy few months since our last\nupdate,” said Ocumetics CEO, Dr. Mark Lee. “We could n...